AI

Marcee Chmait of Providence Digital Innovation Group, Esther Kim of Mass General Brigham, and Kali Arduini Idhe of Northwestern Medicine highlight what attendees will learn from the HIMSS25 Smart Health Transformation Preconference Forum.

Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.

The funding, which is NRFC's first medical science investment, will help introduce the company's AI to more health facilities locally and abroad.

Also, a new mobile app in Australia tracks eyelid movement to detect sleep apnoea.

Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.

The EU guidelines highlight prohibitions on harmful manipulation, real-time biometric identification and social scoring.

Gunnar Trommer of BCG X and Erik Adams of BCG give highlights of their upcoming HIMSS25 panel on the capital needed to develop and commercialize AI-powered medical devices and on completing regulatory milestones like 510(k) clearance.

The Series C raise comes less than a year after the company secured $50 million in a Series B funding round.

Ian Shakil, chief strategy officer at Commure, explores the role of AI in clinical documentation and note-taking, emphasizing the importance of keeping humans in the loop and expanding the technology's impact across healthcare.

Patients are interested in AI to try and garner more information about their care or their child's care. Tools like ChatGPT are being utilized more by patients, says Dr. Samuel Browd of UW and Seattle Children's and the CMO at Proprio.